USRetina Appoints Revenue Leader to Accelerate Growth of Retina Technology Platform

By

John Crowley

DENVER—USRetina, a leading independent provider of technology and services specific to retina practices, has expanded its leadership team with the appointment of a new vice president of sales, John Crowley. The change reflects a strategic approach to long-term value and growth for the organization, according to a recent announcement about the appointment. Crowley is a 20-year veteran of the health care industry. Most recently, he served as the vice president of Vital Source GPO, a division of Cardinal Health.

He previously worked at leading health care companies, including Pfizer, AmerisourceBergen and KIM International, where he served as the senior vice president of sales.

“It’s an honor to join a world-class organization that has radically transformed the retina industry,” Crowley said. “This industry is ripe for disruption, as technology has yet to provide practices with the actionable, analytical data they need. USRetina fundamentally changes how these practices make decisions around drug inventory, finance and, ultimately, patient care.”

“John’s appointment represents the next phase of growth for USRetina,” chief executive officer Ike Nicoll added. “His deep experience and proven track record of success demonstrate a new level of client service and business momentum. He’s got a long history of working with retina practices, understanding their daily challenges, and figuring out how to create value. We couldn’t be more excited to welcome him aboard.”

Earlier this year, USRetina announced other key management hires, along with the launch of RetinaOS, an analytics platform built specifically for retina practices. Since the launch, RetinaOS has been experiencing explosive growth, with a 400 percent increase in practices adopting the platform to take advantage of better drug and financial analytics during a time when patient visits had declined due to pandemic conditions.